Curative Therapy After Atezolizumab and Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma

Clinical trial NCT07091942 · RECRUITING

Trial details

NCT number: NCT07091942
Sponsor: National Taiwan University Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Hepatocellular Carcinoma

Start date: 2025-07-17
Primary completion: 2025-12-31
Enrollment: 1600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.